Differentiation of Viable and Nonviable Myocardium by the Use of Three-Dimensional Tagged MRI in 2-Day-Old Reperfused Canine Infarcts

Circulation - United States
doi 10.1161/01.cir.99.2.284
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Intracellular pH of Canine Subendocardial Purkinje Cells Surviving in 1- Day-Old Myocardial Infarcts

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
1989English

Blood Flow, Flow Reserve, and Glucose Utilization in Viable and Nonviable Myocardium in Patients With Ischemic Cardiomyopathy

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2013English

Reduction of the Size of Infarction by Allopurinol in the Ischemic- Reperfused Canine Heart

Circulation
Cardiovascular MedicinePhysiologyCardiology
1986English

Categorization of Two-Dimensional and Three-Dimensional Stimuli by 18-Month-Old Infants

Infant Behavior and Development
DevelopmentalEducational Psychology
2013English

Changes in Substrate Metabolism and Effects of Excess Fatty Acids in Reperfused Myocardium

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
1988English

Divergent Effects of Inotropic Stimulation on the Ischemic and Severely Depressed Reperfused Myocardium

Circulation
Cardiovascular MedicinePhysiologyCardiology
1982English

Localization of Viable, Ischemic Myocardium by Positron-Emission Tomography With 11c-Palmitate

Circulation
Cardiovascular MedicinePhysiologyCardiology
1981English

-153-The Myocardial Function Under the Reperfused Myocardium : The Effects of Vasodilator and Inotropic Agent

Japanese Circulation Journal
1986English

Passive Targeting of Ischemic-Reperfused Myocardium With Adenosine-Loaded Silica Nanoparticles

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy